Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study

Authors Berstein FM, McCartney DL, Lu AT. et al
Citation eLife. 2022 Mar 29;11:e75374.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/35346416/
PMCID PMC9049976

Read this next

Mayo Clinic study shows AI may improve prediction of colorectal cancer